Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Parkinsonism Relat Disord ; 12(5): 323-6, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16459122

RESUMO

Up to 6% of the general population have essential tremor (ET). In a number of couples both partners may have ET. The clinical profile of ET in children and the parents where both parents and the child have ET remains to be established. We report on two families where both parents and one child have ET. The severity of ET was greater in the children than in either parent. Such families could provide special opportunity to determine relation between genotype and phenotypic expression of ET.


Assuntos
Tremor Essencial/genética , Tremor Essencial/fisiopatologia , Adulto , Idoso , Progressão da Doença , Feminino , Movimentos da Cabeça , Humanos , Masculino , Pessoa de Meia-Idade , Postura/fisiologia , Extremidade Superior/fisiologia
3.
Int J Mol Med ; 15(6): 987-91, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15870904

RESUMO

There is widespread brain pathology in Parkinson's disease (PD), with the primary pathology in the substantia nigra. Oxidative stress is believed to play a role in cell death in PD. Rotenone is a mitochondrial toxin which can produce Parkinson syndrome (PS) in rats. Myristoyl-CoA:protein N-myristoyltransferase (NMT), which catalyzes the co-translational transfer of myristate from myristoyl-CoA to the amino-terminal glycine residue of selected polypeptides, is increased in the myocardium of ischemia-reperfusion rat model myocardium. Animals received rotoneone (n=10) or placebo vehicle (n=6) via Alzet osmotic pumps. Mean cardiac muscle NMT activity of placebo treated (control) rats was 0.608+/-0.366 units/mg protein. Rats with mild or no detectable PS features on rotenone showed slight (mean 0.853+/-0.192) but insignificantly increased activity. Rats that had moderately severe PS features had higher level of NMT activity (mean 1.223+/-0.057), which was borderline significant compared to controls (P=0.066). Rats with severe PS features had the highest NMT activity (1.353+/-0.128) which was significantly greater compared to controls (P=0.003) and to the rats that had equivocal or no motor slowing (P=0.005). Our data show cardiac metabolic dysfunction in a rotenone rat model of PS. The severity of this change correlates with the severity of motor manifestations. Further studies of NMT activity in human PD cases and patients with cardiomyopathy of unknown cause may provide valuable information in these disorders.


Assuntos
Acil Coenzima A/metabolismo , Aminofilina/metabolismo , Atropina/metabolismo , Modelos Animais de Doenças , Nitroglicerina/metabolismo , Papaverina/metabolismo , Doença de Parkinson/enzimologia , Fenobarbital/metabolismo , Rotenona/farmacologia , Animais , Combinação de Medicamentos , Humanos , Masculino , Ratos , Ratos Endogâmicos Lew
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...